05/31/2024 3:56 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:10 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
04/02/2024 7:33 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 7:33 PM | Monopar Therapeutics (Issuer) Tsuchimoto Kim R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 7:35 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 6:01 AM | Monopar Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/07/2024 7:30 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 12:45 PM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 5:59 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 6:36 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:37 PM | Monopar Therapeutics (Issuer) STARR CHRISTOPHER M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:38 PM | KLAUSNER ARTHUR J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:39 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:40 PM | Brown Michael J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:40 PM | Anderson Raymond (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:33 PM | Monopar Therapeutics (Issuer) RIOUX PATRICE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 6:34 PM | Monopar Therapeutics (Issuer) Tsuchimoto Kim R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:01 AM | Monopar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 6:35 PM | Monopar Therapeutics (Issuer) STARR CHRISTOPHER M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 6:36 PM | Monopar Therapeutics (Issuer) Tsuchimoto Kim R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 6:37 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 6:30 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 6:31 PM | Anderson Raymond (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 6:32 PM | Brown Michael J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 6:34 PM | KLAUSNER ARTHUR J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 4:16 PM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 6:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2023 6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The Worst is Yet to Come… (Ad) Millions of Unsuspecting Americans Could be Wiped Out…
Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly. Click here to stream this controversial exposé now. |
07/03/2023 5:45 PM | Monopar Therapeutics (Issuer) Robinson Chandler (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 5:46 PM | Monopar Therapeutics (Issuer) Tsuchimoto Kim R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 5:46 PM | Monopar Therapeutics (Issuer) STARR CHRISTOPHER M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 5:49 PM | KLAUSNER ARTHUR J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 5:49 PM | Brown Michael J (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 5:50 PM | Anderson Raymond (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 5:51 PM | Cittadine Andrew (Reporting) Monopar Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 6:01 AM | Monopar Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |